<DOC>
	<DOCNO>NCT02930993</DOCNO>
	<brief_summary>This single-arm , open-label , one center , dose escalation clinical study , determine safety efficacy infusion autologous T cell engineer express chimeric antigen receptor target mesothelin adult patient mesothelin positive , recurrent metastatic malignant tumor .</brief_summary>
	<brief_title>Anti-mesothelin CAR T Cells Patients With Recurrent Metastatic Malignant Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>1. patient mesothelin positive , recurrent metastatic malignant tumor , include limited pancreatic adenocarcinoma , ovarian cancer , pleural mesothelioma . 2. relapse metastatic standard treatment 3. measurable tumor RECIST1.1 standard 4. patient 18 70 year old . 5. life expectancy &gt; 3months . 6 . KPS ≥70 . 7. satisfactory major organ function : adequate heart function LVEF≥50 % ; obvious abnormities ECG ; pulse oximetry ≥ 90 % ; cockcroftgault creatinine clearance≥40 ml/min ; alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) ≤3ULN ; Bilirubin ≤2.0 mg/dl . 8 . Blood : Hgb ≥ 80 g/L , ANC ≥ 1×10^9/L , PLT ≥ 50×10^9/L . 9. woman reproductive potential must negative pregnancy test . Male female reproductive potential must agree use birth control study one year post study . 1. patient prior history autoimmune disease disease need longterm use systemic hormone drug immunosuppressive therapy 2. active infection . 3 . HIV positive . 4. active hepatitis B virus infection hepatitis C virus infection . 5. currently enrol study . 6. patient , opinion investigator , may eligible able comply study . 7. patient allergic disease , allergic T cell product biological agent use study . 8. patient whose tumor metastasize bone marrow , clinical sign bone metastasis , bone joint pain . 9. patient brain metastasis sign brain metastasis , loss selfconsciousness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>